What is a common side effect of bile acid sequestrants?

A. Hyperglycemia: Fenofibrate primarily affects lipid metabolism and is not commonly associated with causing high blood glucose levels. While monitoring is important in clients with diabetes, hyperglycemia is not a typical adverse effect of this medication.

B. Increased hemoglobin: Fenofibrate does not influence hemoglobin levels. Any changes in hemoglobin are unlikely to be related to fenofibrate therapy and should prompt evaluation for other underlying conditions.

C. Hepatotoxicity: Fenofibrate can cause liver injury, evidenced by elevated liver enzymes or other signs of hepatotoxicity. Monitoring liver function tests before and during therapy is essential to detect adverse effects early and prevent serious liver complications.

D. Fever: Fever is not a recognized adverse effect of fenofibrate. If a client develops fever, other causes such as infection or unrelated inflammatory processes should be investigated rather than attributing it to the medication.

A. Flu-like symptoms: Clopidogrel can cause adverse effects related to platelet inhibition and immune response, including flu-like symptoms such as fever, malaise, and body aches. Monitoring for these symptoms helps identify early reactions that may require intervention or discontinuation of the medication.

B. Constipation: Constipation is not commonly associated with clopidogrel use. While gastrointestinal discomfort may occur in some clients, it is not a primary adverse effect to monitor when administering this antiplatelet therapy.

C. Nervousness: Nervousness or anxiety is not a recognized adverse effect of clopidogrel. Monitoring for neurological or psychological changes is not typically necessary for this medication unless other comorbidities exist.

D. Hypertension: Clopidogrel does not usually cause elevated blood pressure. Monitoring blood pressure is part of routine assessment but is not specifically related to clopidogrel therapy or its adverse effects.